UPMC to help build new drug R&D facility

UPMC is teaming up with PharmaLogic Holdings to construct one of the largest U.S.-based facilities for radiopharmaceutical research, production and distribution in Pittsburgh, the two organizations said June 21. 

PharmaLogic will manage and invest in building a Current Good Manufacturing Practice facility on UPMC's campus, and the system will co-fund and "be the anchor clinical customer and provide strategic, research and operational support," according to a news release from Pittsburgh-based UPMC.

"Under the terms of the non-exclusive agreement, PharmaLogic and UPMC will translate investigational radiopharmaceuticals into clinically relevant drugs for the diagnosis and treatment of cancer, cardiovascular and other diseases," the release said. 

A spokesperson told Becker's the facility is forecasted to be about 14,500 square feet.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like